Encapsulating pig islets has been suggested as effective in reducing xenogeneic immune rejection and prolonging graft survival and was tested in two clinical studies in T1D patients but showed only minimal reduction in their daily insulin needs [22,23,24,25,26]. This evidence concerns the gene INS and type 1 diabetes mellitus.